Literature DB >> 15982248

Chronic blood transfusion therapy practices to treat strokes in children with sickle cell disease.

Terianne Lindsey1, Nutrena Watts-Tate, Elaine Southwood, Julie Routhieaux, Janice Beatty, Calamaras Diane, Melissa Phillips, Gwendolyn Lea, Evelyn Brown, Michael R DeBaun.   

Abstract

PURPOSE: To identify variations in practices used by nurses for pediatric patients with sickle cell disease (SCD) receiving chronic blood transfusion therapy for strokes. DATA SOURCES: Descriptive study of a convenience sample of 11 nurses who care for children with SCD from nine institutions completed a closed-ended questionnaire consisting of 37 items. Responses reflected practice experience with a total of 189 transfused patients with SCD.
CONCLUSIONS: A wide range of nursing practices exists for blood transfusion therapy for children with SCD and strokes. Manual partial exchange transfusion (66%) was the most commonly used method for blood transfusion in children with strokes reported among the nurses surveyed. Simple transfusions and erythrocytapheresis account for 21% and 13% of the practices reported. Opportunities exist to establish evidence-based nursing care guidelines to improve the care of children with strokes receiving blood transfusion therapy. IMPLICATIONS FOR PRACTICE: A wide range of local standard care guidelines for blood transfusion therapy exists. The results of this survey indicate that partial manual exchange transfusion is the most commonly used method of chronic blood transfusion therapy in children with SCD and stroke despite the fact that the magnitude of benefit in comparison with simple transfusion has not been established. Factors such as peripheral venous access, compliance with current chelation regimen, and the presence of antibodies are important considerations in the choice of method.

Entities:  

Mesh:

Year:  2005        PMID: 15982248     DOI: 10.1111/j.1745-7599.2005.0046.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  3 in total

1.  How I treat and manage strokes in sickle cell disease.

Authors:  Adetola A Kassim; Najibah A Galadanci; Sumit Pruthi; Michael R DeBaun
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 2.  Prospects for primary stroke prevention in children with sickle cell anaemia.

Authors:  Lori C Jordan; James F Casella; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

3.  Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in China.

Authors:  Gui-Ping Xu; Li-Fang Wu; Jing-Jing Li; Qi Gao; Zhi-Dong Liu; Qiong-Hua Kang; Yi-Jun Hou; Luo-Chuan Zhang; Xiao-Mei Hu; Jie Li; Juan Zhang
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.